Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System
Journal of Clinical Oncology- United States
doi 10.1200/jco.2010.28.3978
Full Text
Abstract
Available in
Date
May 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)